Prograf generics begin to bite at Astellas
03 February 2010
Ian Haydock
Please Login to read the full article.
03 February 2010
Ian Haydock
ian.haydock@informa.com
Astellas's total net sales edged up by 2% to ¥772.8 billion ($8.52 billion) in the nine months to December 31st, with growth being constrained by the strong yen and increasing generic competition for top product Prograf (tacrolimus).
Currency effects knocked ¥40.5 billion off the...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
